13th Annual World Clinical Biomarkers & CDx Summit

Visit us at booth E30 to learn how we can partner for end-to-end support of your research and development program.

We help you analyze more data in more depth, so you can produce more effective therapies. Attending the 13th World Clinical Biomarkers & CDx Summit? Schedule a meeting with our team to discuss our:

  • AI-powered digital pathology solutions
  • Immuno-oncology biomarker development and validation
  • Spatial biology and molecular diagnostics analysis
  • Immunotherapy clinical trial support
  • CDx development
  • Regulatory guidance
Tom Turi, Ph.D.

Tom Turi, Ph.D.

Chief Scientific Officer at Flagship Biosciences

Friday, September 8 at 12:30 pm

Enabling Precision Medicine Through Digital Pathology

  1. Expanding the repertoire of biomarkers for patient stratification
  2. Implementing digital pathology as an integral component of clinical trials
  3. Validation of digital pathology solutions

Join Flagship CSO, Tom Turi, and other industry experts to address critical challenges and discover insights. Across 2 days, 50+ world-class industry stakeholders will address the most critical challenges in Biomarker Discovery & Translational Development, Clinical Biomarker Development, and CDx Development & Commercialization.

Interested in Partnering with Us?

Validated Assays for Use in Immunotherapy Research & Development.

  • Customizable options optimized to your needs and validation requirements
  • Ability to create multiplex assays to characterize complex cellular interactions

Tailored Companion Diagnostics solutions to meet your research needs

  • Valuable insights that can inform clinical decisions and support drug development programs
  • Expertise in developing assays for oncology, immune-oncology, neuromuscular disorders, and cell & gene therapies for rare diseases
  • Preliminary research, tissue biomarker assay optimization, and assay validation

Tissue-Based Pathology Companion Diagnostic Development for Regulated Applications

  • Expertise in novel biomarker and tissue analyses
  • Regulatory strategy and support
  • Consult with scientific experts

Driving Your Biomarker Strategy: Facts by numbers

  • View our resume and history to learn why Flagship is the premier partner for your study
  • See the full list of spatial biology services that empower confident clinical decision making
  • See the benefits with a fully integrated team of scientists and pathologists

Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.

Recent Posts

Spatial Biology for Drug Development Summit

Visit Flagship at the Spatial Biology for Drug Development Summit. October 11-13, 2023. Join us at the inaugural Spatial Biology for Drug Development Summit to explore implementation strategies, challenges in interpretation, and how this rapidly changing technology is...

June 2023 Annual Meeting

Flagship Bioscience is your source for spatial biology expertise, moving your research forward every step of the way. Our mission is to explore complex biomarkers within the context of disease in order to advance your precision medicine strategy. Attending the 2023...

American Society of Gene and Cell Therapy Annual Meeting

Visit us at booth 821 at the ASGCT Annual Meeting.  We help you analyze more data in more depth, so you can produce more effective therapies. Attending the ASGCT Annual Meeting? Schedule a meeting with our team to discuss our: AI-powered digital pathology solutions...

American Association for Cancer Research Annual Meeting

Visit Us at Booth 2866 in the West Building, Level 2 Flagship Biosciences is your source for spatial biology expertise, moving your research forward every step of the way. Our mission is to explore complex biomarkers within the context of disease in order to advance...

Gene Therapy for Muscular Disorders

Reuniting 100+ leading experts in biotech, pharma, and academia. February 21-23, 2023.  We’re headed to Boston to join other leading experts in biotech, pharma and academia to discuss obstacles in clinical trials and strategies for delivering safer and more effective...